(Q36365485)

13 August 2017

1 reference

title

Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature (English)

1 reference

13 August 2017

main subject

paraneoplastic pemphigus

1 reference

1 reference

P Coll

12

0 references

Luis Puig

7

object named as

L Puig

1 reference

13 August 2017

Ma Barnadas

1

1 reference

13 August 2017

E Roe

2

1 reference

13 August 2017

S Brunet

3

1 reference

13 August 2017

P Garcia

4

1 reference

13 August 2017

P Bergua

5

1 reference

13 August 2017

L Pimentel

6

1 reference

13 August 2017

A Francia

8

1 reference

13 August 2017

R García

9

1 reference

13 August 2017

C Gelpí

10

1 reference

13 August 2017

J Sierra

11

1 reference

13 August 2017

A Alomar

13

1 reference

13 August 2017

publication date

1 January 2006

1 reference

Journal of the European Academy of Dermatology and Venereology

13 August 2017

published in

1 reference

13 August 2017

volume

20

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

69-74

1 reference

Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

21 January 2018

Paraneoplastic pemphigus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

Paraneoplastic pemphigus: a case of prolonged survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01345.X

10.1111/J.1468-3083.2005.01345.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference